Inventor · disambiguated record
Han-Zhong Zhang
Also filed as: ZHANG HAN · ZHANG HAN-ZHONG
33 granted patents·24 pending applications·762 citations·filing 1998–2024
97Inventor score
Files withCYTOVIA INC25TURNING POINT THERAPEUTICS INC9SERES THERAPEUTICS INC6UNIV MASSACHUSETTS4FOX JOSEPH2
Top patents by PatentIndex Score
57 records- 0197US6335429B1Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereofCYTOVIA INC·Filed 2000·Granted Jan 1, 2002·151 cites·18 claims
- 0296US10881696B2Network-based microbial compositions and methodsSERES THERAPEUTICS INC·Filed 2018·Granted Jan 5, 2021·10 cites·17 claims
- 0396US9956282B2Bacterial compositions and methods of use thereof for treatment of immune system disordersSERES THERAPEUTICS INC·Filed 2014·Granted May 1, 2018·10 cites·11 claims
- 0495US11185562B2Compositions and methods for inhibition of pathogenic bacterial growthSERES THERAPEUTICS INC·Filed 2014·Granted Nov 30, 2021·12 cites·16 claims
- 0595US11155563B2Macrocyclic compounds and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2021·Granted Oct 26, 2021·3 cites·3 claims
- 0695US7041685B2Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Granted May 9, 2006·118 cites·12 claims
- 0794US10745416B2Macrocyclic compounds for treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2020·Granted Aug 18, 2020·4 cites·29 claims
- 0894US10076546B2Network-based microbial compositions and methodsSERES THERAPEUTICS INC·Filed 2014·Granted Sep 18, 2018·23 cites·12 claims
- 0994US7317029B23,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2006·Granted Jan 8, 2008·36 cites·12 claims
- 1094US6759207B2Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereofCYTOVIA INC·Filed 2001·Granted Jul 6, 2004·46 cites·38 claims
- 1193US7435750B2Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2005·Granted Oct 14, 2008·30 cites·12 claims
- 1293US6462041B1Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2000·Granted Oct 8, 2002·44 cites·54 claims
- 1392US6342611B1Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereofCYTOVIA INC·Filed 1998·Granted Jan 29, 2002·89 cites·41 claims
- 1491US11981684B2Macrocyclic compounds and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2022·Granted May 14, 2024·1 cites·20 claims
- 1591US11286264B2Macrocyclic compounds and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2018·Granted Mar 29, 2022·4 cites·21 claims
- 1691US6248904B1Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereofCYTOVIA INC·Filed 1999·Granted Jun 19, 2001·70 cites·10 claims
- 1788US11666612B2Network-based microbial compositions and methodsSERES THERAPEUTICS INC·Filed 2021·Granted Jun 6, 2023·1 cites·22 claims
- 1888US7144876B23,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2003·Granted Dec 5, 2006·34 cites·14 claims
- 1987US6613762B2Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2002·Granted Sep 2, 2003·18 cites·22 claims
- 2083US7504382B2Protease inhibitors for coronaviruses and SARS-CoV and the use thereofCYTOVIA INC·Filed 2004·Granted Mar 17, 2009·8 cites·1 claims
- 2182US2022249578A1Compositions and methods for inhibition of pathogenic bacterial growthSERES THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2281US7732468B23-aryl-6-aryl-[ 1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and related compounds as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2007·Granted Jun 8, 2010·1 cites·4 claims
- 2380US6716859B2Substituted N′-(Arylcarbonyl)-benzhydrazides, N′(Arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Granted Apr 6, 2004·8 cites·7 claims
- 2479US7622497B2Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2004·Granted Nov 24, 2009·7 cites·4 claims
- 2578US7270801B2Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereofCYTOVIA INC·Filed 2004·Granted Sep 18, 2007·3 cites·18 claims
- 2677US6747052B2Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Granted Jun 8, 2004·5 cites·13 claims
- 2774US7176234B2Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2003·Granted Feb 13, 2007·8 cites·45 claims
- 2872US7135480B2Substituted 1-benzoyl-3-cyano-pyrrolo [1,2-a] quinolines and analogs as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2003·Granted Nov 14, 2006·6 cites·21 claims
- 2972US2022306652A1Macrocyclic compounds for treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3071US11286265B2Macrocyclic compounds for treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2020·Granted Mar 29, 2022·0 cites·15 claims
- 3169US7592143B2Methods of treating diseases responsive to induction of apoptosis and screening assaysCYTOVIA INC·Filed 2004·Granted Sep 22, 2009·3 cites·9 claims
- 3269US2024408238A1Nme2cas9 inlaid domain fusion proteinsUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 3366US2023407295A1Protecting oligonucleotides for crispr guide rnaUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 3465US6984718B2Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereofCYTOVIA INC·Filed 2002·Granted Jan 10, 2006·9 cites·16 claims
- 3562US7074813B2Substituted N′-(arylcarbonyl)-benzhydrazides, N′-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2004·Granted Jul 11, 2006·0 cites·10 claims
- 3660US2025002505A1Synthesis of macroyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3758US2008113946A1N-aryl-5,7-dihydrofuro[3,4-d]pyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYNTOVIA INC·Filed 2007·Application pending·0 cites
- 3857US2008045514A13-Aryl-6-aryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 3955US2002128292A1Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereofFiled 2001·Application pending·0 cites
- 4055US2021388348A1Modified guide rnas for crispr genome editingUNIV MASSACHUSETTS·Filed 2021·Application pending·0 cites
- 4150US2023032664A1Iron-reducing Tessaraccocus Oleiagri Strain DH10 and Applications thereofUNIV YANGTZE·Filed 2021·Application pending·0 cites
- 4249US2005004005A1Methods of treating diseases responsive to Induction of ApoptosisFiled 2004·Application pending·0 cites
- 4348US2007099877A1N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2006·Application pending·0 cites
- 4445US2024238358A1Traditional chinese medicine composition for infectious disease recovery and use thereofCHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 4545US2021087206A1Macrocyclic kinase inhibitors and their useTURNING POINT THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4645US2023113539A1Traditional Chinese medicine for dispersing lung qi and detoxicatingSHANDONG BUCHANG PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 4745US2024261359A1Pharmaceutical composition for use preventing and curing respiratory diseases in winterUNIV TIANJIN TRADITIONAL CHINESE MEDICINE·Filed 2021·Application pending·0 cites
- 4843US10155777B2Trans-cycloheptenes and hetero-trans-cycloheptenes for bioorthogonal couplingFOX JOSEPH·Filed 2016·Granted Dec 18, 2018·0 cites·3 claims
- 4943US2007299011A1Appoptosin and uses thereof for treating neurodegenerative disease and cancerCHEN YEGUANG·Filed 2007·Application pending·0 cites
- 5043US2007253957A1Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of ApoptosisCYTOVIA INC·Filed 2005·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →